The National Medicines Policy is being reviewed – Research Australia wants its members included

The lobby states it, represents “the whole of the health and medical research pipeline” and wants the research community to be, “explicitly identified as partners in the NMP.”

Researchers, “have an important role in evaluating innovative programmes delivered under the NMP, including in terms of effectiveness, cost, implementation outcomes and programme sustainability,” RA states.

The NMP now includes health practitioners, the medicines industry and healthcare consumers.